Autism

Dr. Greg Hanley Joins Action Behavior Centers

Executive Director of Compassionate Care AUSTIN, TX / ACCESSWIRE / August 12, 2024 / Action Behavior Centers is thrilled to…

1 year ago

SciSparc’s Collaboration with Clearmind Medicine Continues to Bear Fruit With New Scientific Article Showing MEAI Potential as a Novel Weight Loss Drug

SciSparc has been collaborating with Clearmind Medicine to create effective treatments for obesity and metabolic syndrome by combining SciSparc’s Palmitoylethanolamide…

1 year ago

Harmony Biosciences Reports Strong Second Quarter 2024 Financial Results and Advances Pitolisant High-Dose Program Toward Expected PDUFA Date in 2028

WAKIX® (pitolisant) Net Revenue of $172.8 Million for Second Quarter 2024; ~29% Growth Year-over-Year Next Generation Pitolisant High-Dose (HD) Program…

1 year ago

AbleNet, Inc. Can Now Serve and Support California Medi-Cal Clients with the QuickTalker Freestyle Speech Device

California is dedicated to supporting their state Medicaid recipients with the best possible healthcare professionals and AbleNet has been added…

1 year ago

Yamo Pharmaceuticals Announces Positive Topline Results from Phase 2 Study of L1-79 for the Treatment of the Core Symptoms of Autism

Data shows L1-79 offers a statistically significant improvement compared to placebo in socialization, as well as the investigator- and parent-rated…

1 year ago

Ultragenyx to Present GTX-102 Angelman Syndrome Program Update at the ASF Family Conference and Research Symposium

Presentations will include an encore of the positive interim Phase 1/2 results presented in April at the 76th Annual American…

1 year ago

Beyond Air® to Report First Fiscal Quarter 2025 Financial Results on August 6

GARDEN CITY, N.Y., July 23, 2024 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a…

1 year ago